Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.565
Low: 1.475
Prev. Close: 1.65
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

Mon, 27th Sep 2021 14:17

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

EMIS Group PLC - Leeds, England-based healthcare software company - Names Denise Collis as an additional independent non-executive director. Collis will formally join the board on Friday. Collis is currently non-executive director, chair of the remuneration committee and senior independent director at SThree PLC and non-executive director and chair of the remuneration committee at Smiths News PLC.

----------

Bank of Ireland Group PLC - Dublin-based company - Chief Financial Officer Myles O'Grady steps down to take up a senior finance role in an organisation outside the financial services sector. O'Grady is expected to leave BoI in March 2022 and a process to appoint his successor will now commence. Myles joined BoI in June 2019 as finance director Ireland and was appointed CFO in October 2019 and a member of the board in January 2020.

----------

Empiric Student Property PLC - London-based real estate investment trust - Says Martin Ratchford has been appointed as an independent non-executive director from Friday. Ratchford has held the post of CFO at Frasers Property UK Ltd since June 2018. Empiric also says Jim Prower will resign as a director on the same day as part of a planned succession process.

----------

Fuller, Smith & Turner PLC - London-based brewery - Says Finance Director Adam Councell will step down from his role and from the board on Thursday. Neil Smith will succeed Councell. In order to ensure a smooth handover to Smith, Councell has agreed to provide appropriate support to the business on a consultancy basis until Smith joins the business on November 30.

----------

Powerhouse Energy Group PLC - Bingley, England-based company which is transforming plastics and waste into clean energy - Says Non-Executive Director Allan Vlah will step down at the end of 2021 to concentrate on his other business interests. Powerhouse Energy appoints Keith Riley as a non-executive director with immediate effect. Riley is currently proprietor & chief executive officer of Vismundi Ltd, a consultancy company providing services to the resources and waste management industry.

----------

LSL Property Services PLC - Newcastle, England-based surveying services company - Names James Mack as a non-executive director, with immediate effect. Mack currently serves as CFO & executive director at Barclays Bank UK PLC. James was previously CFO & executive director at Aldermore PLC and Aldermore Group PLC.

----------

Aberdeen Asian Income Fund Ltd - Chelmsford, England-based investment firm - Hires Robert Kirkby as an independent non-executive director with effect from November 1. "Robert is a former advisory partner at KPMG Channel Islands and a fellow of the Institute of Chartered Accountants with a background as a business leader and a track record of establishing a business, growing revenue and building a dynamic team," says Chair Charles Clarke.

----------

Harland & Wolff Group Holdings PLC - Belfast, Northern Ireland-based investment company - Says Clive Richardson, non-executive chair, is stepping down from the board. Richardson's notice period will run until mid-December 2021. Richardson has decided to step down to focus on other activities to which he is already committed, Harland & Wolff says. A formal process to appoint a successor has been initiated and, whilst this progresses, Malcolm Groat, currently chair of the Audit Committee, has been named as interim chair.

----------

Shield Therapeutics PLC - Newcastle, England-based pharmaceutical company - Names Jose Menoyo as vice president & chief medical officer with immediate effect. Prior to joining Shield, Menoyo served as Head of US Medical Affairs at Alexion Pharmaceuticals Inc.

----------

Corcel PLC - London-based natural resource exploration and development company - Names Henry Bellingham as an independent non-executive director, subject the successful conclusion of due diligence procedures. "Henry has a wealth of experience in the natural resources arena, and I am delighted to welcome him to the team at such an exciting time for the business," says Chair James Parsons.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
19 Sep 2018 08:36

Shield Therapeutics irons losses, agrees commercialisation deal

(Sharecast News) - Iron deficiency treatment specialist Shield Therapeutics narrowed losses as revenues grew in the first half of that saw a series of positive developments.

Read more
13 Sep 2018 11:51

Shield Therapeutics Completes Recruitment For Feraccru Trial

LONDON (Alliance News) - Shield Therapeutics PLC said on Thursday it has completed recruitment of patients for the AEGIS-H2H Phase 3b study of oral Feraccru in subjects suffering from inflammatory

Read more
26 Jul 2018 13:05

Shield Therapeutics Appoints Hans-Peter Hasler To Board

LONDON (Alliance News) - Shield Therapeutics PLC, a commercial stage pharmaceutical company, said Thursday that it has appointed Hans-Peter Hasler as non-executive director with immediate is the a

Read more
20 Jun 2018 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25

Read more
14 Jun 2018 13:48

Shield Therapeutics Reports Positive Results From Feraccru Study

LONDON (Alliance News) - Pharmaceutical company Shield Therapeutics PLC said Thursday it has had positive top-line results from its paediatric phase I pharmacokinetics study of its ferric iron is

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
6 Jan 2017 08:12

Shield Therapeutics sees 'encouraging' demand for oral iron product in England, Germany

(ShareCast News) - AIM-listed pharmaceutical Shield Therapeutics saw "encouraging" demand for its oral iron product in the England and Germany. The company said is seeing "very encouraging signals of demand" after only six months since the commercial launch of Feraccru, which treats of iron deficien

Read more
14 Jun 2016 09:17

Shield Therapeutics Reports Widened Pretax Loss In Maiden 2015 Results

Read more
7 Jun 2016 15:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
26 Feb 2016 09:17

Shield Therapeutics Starts Trading, Gets European Feraccru Approval (ALLIPO)

Read more
12 Feb 2016 11:50

Shield Therapeutics Raises GBP32.5 Million In Delayed AIM IPO (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.